| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiviral activity of selected antimicrobial peptides against vaccinia virus
|
Mohan, Ketha V.K.
|
|
2010
|
86 |
3 |
p. 306-311
6 p.
|
article
|
| 2 |
Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice
|
Rowe, Jenny
|
|
2010
|
86 |
3 |
p. 276-285
10 p.
|
article
|
| 3 |
Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development
|
Bonnafous, Pascale
|
|
2010
|
86 |
3 |
p. 316-319
4 p.
|
article
|
| 4 |
Dengue virus replicons: Production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity
|
Massé, Nicolas
|
|
2010
|
86 |
3 |
p. 296-305
10 p.
|
article
|
| 5 |
Editorial Board
|
|
|
2010
|
86 |
3 |
p. ii-
1 p.
|
article
|
| 6 |
Efficacy of 2′-C-methylcytidine against yellow fever virus in cell culture and in a hamster model
|
Julander, Justin G.
|
|
2010
|
86 |
3 |
p. 261-267
7 p.
|
article
|
| 7 |
Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1
|
Said, Joanna
|
|
2010
|
86 |
3 |
p. 286-295
10 p.
|
article
|
| 8 |
Marine compounds and their antiviral activities
|
Yasuhara-Bell, Jarred
|
|
2010
|
86 |
3 |
p. 231-240
10 p.
|
article
|
| 9 |
Notes to Authors
|
|
|
2010
|
86 |
3 |
p. CO3-
1 p.
|
article
|
| 10 |
Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus
|
Sauerbrei, A.
|
|
2010
|
86 |
3 |
p. 246-252
7 p.
|
article
|
| 11 |
Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro
|
Bader, Ted
|
|
2010
|
86 |
3 |
p. 241-245
5 p.
|
article
|
| 12 |
Slow binding–tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation
|
Samuele, Alberta
|
|
2010
|
86 |
3 |
p. 268-275
8 p.
|
article
|
| 13 |
The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro
|
Drogan, Daniel
|
|
2010
|
86 |
3 |
p. 312-315
4 p.
|
article
|
| 14 |
The rare HIV-1 gp41 mutations 43T and 50V elevate enfuvirtide resistance levels of common enfuvirtide resistance mutations that did not impact susceptibility to sifuvirtide
|
Covens, Kris
|
|
2010
|
86 |
3 |
p. 253-260
8 p.
|
article
|
Journal description